Categories: Wire Stories

2020 Insights into the Indian Cough, Cold and Allergy (Hay Fever) Remedies Industry – Pinpoint Growth Sectors – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Cough, Cold and Allergy (Hay Fever) Remedies in India” report has been added to ResearchAndMarkets.com’s offering.

COVID-19 has made consumers more conscious of symptoms such as throat itches, sore throats, and coughs, as well as colds, and encouraged them to take a more proactive approach to the treatment of such symptoms. Moreover, this strengthened consumers’ desire to stock up on medication for coughs and colds, especially under the strict lockdown conditions prevailing during the period from March to June.

The Cough, Cold and Allergy (Hay Fever) Remedies in India report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2015-2019, allowing you to identify the sectors driving growth. Forecasts to 2024 illustrate how the market is set to change.

Product coverage: Antihistamines/Allergy Remedies (Systemic), Combination Products – Cough, Cold and Allergy (Hay Fever) Remedies, Cough Remedies, Decongestants, Medicated Confectionery, Paediatric Cough, Cold and Allergy Remedies, Pharyngeal Preparations.

Data coverage: Market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

  • Get a detailed picture of the Cough, Cold and Allergy (Hay Fever) Remedies market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.

Key Topics Covered:

1. KEY DATA FINDINGS

2. 2020 IMPACT

  • Fast relief products favoured over traditional formats
  • Home seclusion contributes to dip in growth
  • Procter & Gamble retains lead as lockdown affects supply chain

3. RECOVERY AND OPPORTUNITIES

  • Ayurvedic tradition provides potential for revival of natural trend
  • Pollution set to generate demand for cough, cold and allergy (hay fever) remedies
  • Potential for further expansion of online pharmacies

4. CATEGORY DATA

  • Table 1 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2015-2020
  • Table 2 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2015-2020
  • Table 3 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2016-2020
  • Table 4 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2017-2020
  • Table 5 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2020-2025
  • Table 6 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2020-2025

5. EXECUTIVE SUMMARY

  • COVID-19 impact on consumer health
  • COVID-19 country impact
  • Company response
  • Retailing shift
  • What next for consumer health?

6. MARKET INDICATORS

  • Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2015-2020
  • Table 8 Life Expectancy at Birth 2015-2020

7. MARKET DATA

  • Table 9 Sales of Consumer Health by Category: Value 2015-2020
  • Table 10 Sales of Consumer Health by Category: % Value Growth 2015-2020
  • Table 11 NBO Company Shares of Consumer Health: % Value 2016-2020
  • Table 12 LBN Brand Shares of Consumer Health: % Value 2017-2020
  • Table 13 Distribution of Consumer Health by Format: % Value 2015-2020
  • Table 14 Distribution of Consumer Health by Format and Category: % Value 2020
  • Table 15 Forecast Sales of Consumer Health by Category: Value 2020-2025
  • Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2020-2025

8. APPENDIX

  • OTC registration and classification
  • Vitamins and dietary supplements registration and classification
  • Self-medication/self-care and preventive medicine

9. GLOBAL MACROECONOMIC ENVIRONMENT

10. GLOBAL INDUSTRY ENVIRONMENT

11. DISCLAIMER

12. DEFINITIONS

13. SOURCES

For more information about this report visit https://www.researchandmarkets.com/r/eutn9n

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Alex

Recent Posts

Oasis Calls for Improved Shareholder Return & Votes Against Chairman, Two Directors at Kumagai Gumi

(Stock Code: 1861 JT) *Oasis proposes a dividend of JPY160 per share *Oasis recommends shareholders…

55 mins ago

AGBA Solidifies Market Leadership with Expansion Plans and Focus on Tech/Fintech Innovation

LOS ANGELES, May 15, 2024 (GLOBE NEWSWIRE) -- NASDAQ-listed, AGBA Group Holding Limited (“AGBA” or…

3 hours ago

Karooooo Reports Strong Customer Acquisition With Annual EPS up 24% and Q4 EPS up by 45%

SINGAPORE--(BUSINESS WIRE)--Karooooo, that owns 100% of Cartrack, a leading provider of data analytics and business…

3 hours ago

ISS, an Independent Proxy Solicitation Firm, Recommends Voting “FOR” Each of the Five Proposals at Westwater’s 2024 Annual Shareholder Meeting Scheduled for May 30th

CENTENNIAL, Colo.--(BUSINESS WIRE)--Westwater Resources, Inc. (NYSE American: WWR) an energy technology and battery-grade natural graphite…

4 hours ago

Chegg Strengthens its Academic Advisory Board in UK and Australia, Launches New Student Advisory Council

SANTA CLARA, Calif.--(BUSINESS WIRE)--Chegg, Inc. (NYSE: CHGG) today announced the newest members of its Academic…

4 hours ago

Fluor Opens Second Office in India to Increase Execution Capacity

Vadodara office will supplement Fluor’s existing operations in New Delhi IRVING, Texas--(BUSINESS WIRE)--#FluorBuildsABetterWorld--Fluor Corporation (NYSE:…

4 hours ago